Incidence of Group B Streptococcus Disease in Infants in China: An Updated Systematic Review and Meta-analysis

Yijun Ding1, Yingfen Hsia2, Colleen O'Sullivan3

  • 1Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.

Insights

Group B Streptococcus (GBS) incidence in Chinese infants under three months has decreased to 0.41 cases per 1000 live births. This reduction may be linked to new intrapartum antibiotic prophylaxis policies.

Area of Science:

  • Neonatal infectious diseases
  • Epidemiology of bacterial infections
  • Public health interventions

Background:

  • Group B Streptococcus (GBS) remains a significant cause of neonatal infections.
  • Previous systematic reviews have established baseline incidence rates in infants.
  • Updated epidemiological data is crucial for assessing current disease burden and intervention effectiveness.

Approach:

  • Conducted a systematic review and meta-analysis of recent GBS studies in infants <3 months in China.
  • Employed the same rigorous methodology as previous reviews for consistent comparison.
  • Calculated updated incidence rates and confidence intervals.

Key Points:

  • The updated incidence of GBS in infants <3 months in China is 0.41 cases per 1000 live births (95% CI, 0.32-0.51).
  • This represents a decrease from the previously reported incidence of 0.55 per 1000 live births.
  • The implementation of new intrapartum antibiotic prophylaxis policies is a potential contributing factor to this observed reduction.

Conclusions:

  • Recent intrapartum antibiotic prophylaxis policies may have successfully reduced GBS incidence in neonates in China.
  • Continued surveillance and analysis are necessary to confirm the long-term impact of these public health strategies.
  • Findings provide valuable insights for global GBS prevention efforts.